The market of non-registered pharmaceutical products is growing fast in number and overall costs, not only in the Netherlands, but also in other European countries.
These products often give the impression that the consumer may expect « an effect as from a drug ».
Legally, there is a clear distinction between « drugs » and « commodities » in the Netherlands; the question is whether legislation and practice concur.
In an investigation we analysed texts of advertisements for non-registered pharmaceutical products published in a popular magazine.
Mots-clés Pascal : Législation, Commercialisation, Pays Bas, Europe, Médicament, Autorisation, Publicité, Réglementation
Mots-clés Pascal anglais : Legislation, Marketing, Netherlands, Europe, Drug, Licence procedure, Advertising, Regulation
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0199978
Code Inist : 002B30A09. Création : 199406.